Trials / Completed
CompletedNCT00136994
IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)
An Open Trial to Evaluate the Efficacy and Tolerability of Ziprasidone IM and Oral in Patients With Psychosis and Acute Agitation.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 160 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate efficacy and tolerability of Ziprasidone IM and oral in agitated patients with acute exacerbation of schizophrenia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ziprasidone |
Timeline
- Start date
- 2003-03-01
- Completion
- 2005-11-01
- First posted
- 2005-08-29
- Last updated
- 2021-02-21
Locations
34 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00136994. Inclusion in this directory is not an endorsement.